Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Non-Current Deferred Tax Liability came in at $18.0 million in Q2 2026, up 28.57% on a YoY basis from $14.0 million in Q2 2025, and down 5.26% quarter-over-quarter from $19.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Non-Current Deferred Tax Liability for 6 consecutive years, with $18.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 28.57% year-over-year to $18.0 million; the trailing twelve-month figure through Jun 2026 stood at $18.0 million (up 28.57% YoY), and the FY2025 full-year result was $19.0 million, down 83.62% from the prior year.
- Non-Current Deferred Tax Liability declined to $18.0 million in Q2 2026 per BLCO's latest filing, from $19.0 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $118.0 million in Q4 2023 and bottomed at $10.0 million in Q2 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $36.1 million across 5 years, with a median of $14.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability jumped 120.75% in 2022, then tumbled 86.41% in 2023.
- Over 5 years, Non-Current Deferred Tax Liability stood at $117.0 million in 2022, then grew by 0.85% to $118.0 million in 2023, then declined by 1.69% to $116.0 million in 2024, then plunged by 83.62% to $19.0 million in 2025, then dropped by 5.26% to $18.0 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $18.0 million, $19.0 million, and $19.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 116.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 118.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 14.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Mar 31, 2022 | 103.00 Mn |
| Dec 31, 2021 | 53.00 Mn |